Unknown

Dataset Information

0

Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients.


ABSTRACT: Certain host single nucleotide polymorphisms (SNPs) affect the likelihood of a sustained virological response (SVR) to treatment in subjects infected with hepatitis C virus (HCV). SNPs in the promoters of interleukin (IL)-10 (-1082 A/G, rs1800896), myxovirus resistance protein 1 (-123 C/A, rs17000900 and -88 G/T, rs2071430) and tumour necrosis factor (TNF) (-308 G/A, rs1800629 and -238 G/A, rs361525) genes and the outcome of PEGylated ?-interferon plus ribavirin therapy were investigated. This analysis was performed in 114 Brazilian, HCV genotype 1-infected patients who had a SVR and in 85 non-responders and 64 relapsers. A significantly increased risk of having a null virological response was observed in patients carrying at least one A allele at positions -308 [odds ratios (OR) = 2.58, 95% confidence intervals (CI) = 1.44-4.63, p = 0.001] or -238 (OR = 7.33, 95% CI = 3.59-14.93, p < 0.001) in the TNF promoter. The risk of relapsing was also elevated (-308: OR = 2.87, 95% CI = 1.51-5.44, p = 0.001; -238: OR = 4.20, 95% CI = 1.93-9.10, p < 0.001). Multiple logistic regression of TNF diplotypes showed that patients with at least two copies of the A allele had an even higher risk of having a null virological response (OR = 16.43, 95% CI = 5.70-47.34, p < 0.001) or relapsing (OR = 6.71, 95% CI = 2.18-20.66, p = 0.001). No statistically significant association was found between the other SNPs under study and anti-HCV therapy response.

SUBMITTER: Grandi T 

PROVIDER: S-EPMC4131788 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients.

Grandi Tarciana T   Silva Cláudia Maria Dornelles da CM   Amaral Karine Medeiros KM   Picon Paulo Dornelles PD   Costi Cintia C   Fré Nicole Nascimento da NN   Fiegenbaum Marilu M   Gregianini Tatiana Schäffer TS   Niel Christian C   Rossetti Maria Lucia Rosa ML  

Memorias do Instituto Oswaldo Cruz 20140601 3


Certain host single nucleotide polymorphisms (SNPs) affect the likelihood of a sustained virological response (SVR) to treatment in subjects infected with hepatitis C virus (HCV). SNPs in the promoters of interleukin (IL)-10 (-1082 A/G, rs1800896), myxovirus resistance protein 1 (-123 C/A, rs17000900 and -88 G/T, rs2071430) and tumour necrosis factor (TNF) (-308 G/A, rs1800629 and -238 G/A, rs361525) genes and the outcome of PEGylated α-interferon plus ribavirin therapy were investigated. This a  ...[more]

Similar Datasets

| S-EPMC8209664 | biostudies-literature
| S-EPMC6177181 | biostudies-literature
| S-EPMC4161555 | biostudies-literature
| S-EPMC2956720 | biostudies-literature
| S-EPMC8743915 | biostudies-literature
| S-EPMC5376802 | biostudies-literature
| S-EPMC6250438 | biostudies-literature
| S-EPMC3602580 | biostudies-literature
| S-EPMC5346759 | biostudies-literature
| S-EPMC3475979 | biostudies-literature